|
WO1999010349A1
(en)
|
1997-08-22 |
1999-03-04 |
Zeneca Limited |
Oxindolylquinazoline derivatives as angiogenesis inhibitors
|
|
EP1006113A1
(en)
|
1998-12-02 |
2000-06-07 |
Pfizer Products Inc. |
Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use to inhibit abnormal cell growth
|
|
UA71945C2
(en)
|
1999-01-27 |
2005-01-17 |
Pfizer Prod Inc |
Substituted bicyclic derivatives being used as anticancer agents
|
|
GB9918057D0
(en)
*
|
1999-07-30 |
1999-10-06 |
Univ Bristol |
Therapeutic agents
|
|
UA74803C2
(uk)
|
1999-11-11 |
2006-02-15 |
Осі Фармасьютікалз, Інк. |
Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування
|
|
GB0010757D0
(en)
*
|
2000-05-05 |
2000-06-28 |
Astrazeneca Ab |
Chemical compounds
|
|
WO2001094353A1
(en)
*
|
2000-06-06 |
2001-12-13 |
Pfizer Products Inc. |
Thiophene derivatives useful as anticancer agents
|
|
MXPA03000874A
(es)
*
|
2000-08-09 |
2003-06-06 |
Astrazeneca Ab |
Compuestos quimicos.
|
|
CN1474815A
(zh)
|
2000-09-20 |
2004-02-11 |
Ĭ��ר���ɷ�����˾ |
4-氨基-喹唑啉
|
|
US6503914B1
(en)
|
2000-10-23 |
2003-01-07 |
Board Of Regents, The University Of Texas System |
Thienopyrimidine-based inhibitors of the Src family
|
|
AUPR213700A0
(en)
*
|
2000-12-18 |
2001-01-25 |
Biota Scientific Management Pty Ltd |
Antiviral agents
|
|
KR20020051675A
(ko)
*
|
2000-12-23 |
2002-06-29 |
이상남 |
4-페닐아미노티에노 [3,2-디] 피리미딘 유도체 및 이의제조방법
|
|
PL228041B1
(pl)
|
2001-01-05 |
2018-02-28 |
Amgen Fremont Inc |
Przeciwciało przeciwko receptorowi insulinopodobnego czynnika wzrostu I, zawierajaca go kompozycja farmaceutyczna, sposób jego wytwarzania, zastosowania, linia komórkowa, wyizolowana czasteczka kwasu nukleinowego, wektor, komórka gospodarza oraz zwierze transgeniczne.
|
|
DE60212487T2
(de)
*
|
2001-04-13 |
2006-12-21 |
Pfizer Products Inc., Groton |
Bizyklisch substituierte 4-Aminopyridopyrimidinderivate
|
|
US6995171B2
(en)
|
2001-06-21 |
2006-02-07 |
Agouron Pharmaceuticals, Inc. |
Bicyclic pyrimidine and pyrimidine derivatives useful as anticancer agents
|
|
US7829566B2
(en)
|
2001-09-17 |
2010-11-09 |
Werner Mederski |
4-amino-quinazolines
|
|
AR039067A1
(es)
|
2001-11-09 |
2005-02-09 |
Pfizer Prod Inc |
Anticuerpos para cd40
|
|
AU2002357193A1
(en)
*
|
2001-12-19 |
2003-07-09 |
Smithkline Beecham Corporation |
Thienopyrimidine compounds as protein tyrosine kinase inhibitors
|
|
AU2002364211A1
(en)
*
|
2001-12-21 |
2003-07-15 |
Bayer Pharmaceuticals Corporation |
Thienopyrimidine derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
|
|
AU2003202263A1
(en)
*
|
2002-01-10 |
2003-07-30 |
Bayer Healthcare Ag |
Roh-kinase inhibitors
|
|
JP4469179B2
(ja)
|
2002-01-23 |
2010-05-26 |
バイエル ファーマセチカル コーポレーション |
Ｒｈｏキナーゼ阻害剤としてのピリミジン誘導体
|
|
CA2473910C
(en)
|
2002-01-23 |
2011-03-15 |
Bayer Pharmaceuticals Corporation |
Pyrimidine derivatives as rho-kinase inhibitors
|
|
WO2003064428A1
(en)
*
|
2002-01-29 |
2003-08-07 |
H. Lundbeck A/S |
Furano- and thienopyrimidines as neurokinase inhibitors
|
|
US7071190B2
(en)
|
2002-02-15 |
2006-07-04 |
Rigel Pharmaceuticals, Inc. |
Inhibitors to tubulin polymerization
|
|
US20030225273A1
(en)
*
|
2002-03-21 |
2003-12-04 |
Michaelides Michael R. |
Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
|
|
UA77303C2
(en)
*
|
2002-06-14 |
2006-11-15 |
Pfizer |
Derivatives of thienopyridines substituted by benzocondensed heteroarylamide useful as therapeutic agents, pharmaceutical compositions and methods for their use
|
|
KR20050067383A
(ko)
|
2002-08-06 |
2005-07-01 |
아스트라제네카 아베 |
Ｔｉｅ2(ｔｅｋ) 활성을 갖는 축합 피리딘 및 피리미딘
|
|
CL2003002353A1
(es)
*
|
2002-11-15 |
2005-02-04 |
Vertex Pharma |
Compuestos derivados de diaminotriazoles, inhibidores d ela proteina quinasa; composicion farmaceutica; procedimiento de preparacion; y su uso del compuesto en el tratamiento de enfermedades de desordenes alergicos, proliferacion, autoinmunes, condic
|
|
US7276519B2
(en)
|
2002-11-25 |
2007-10-02 |
Wyeth |
Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors
|
|
CL2003002287A1
(es)
*
|
2002-11-25 |
2005-01-14 |
Wyeth Corp |
COMPUESTOS DERIVADOS DE TIENO[3,2-b]-PIRIDINA-6-CARBONITRILOS Y TIENEO[2,3-b]-PIRIDINA-5-CARBONITRILOS, COMPOSICION FARMACEUTICA, PROCEDIMIENTO DE PREPARACION Y COMPUESTOS INTERMEDIARIOS, Y SU USO EN EL TRATAMIENTO DEL CANCER, APOPLEJIA, OSTEOPOROSIS
|
|
MXPA05006676A
(es)
|
2002-12-19 |
2005-08-16 |
Pfizer |
Compuestos de indazol y composiciones farmaceuticas para inhibir proteinquinasas, y procedimientos para su uso.
|
|
RS20060097A
(en)
|
2002-12-20 |
2008-11-28 |
Pfizer Products Inc., |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
|
MXPA05009063A
(es)
|
2003-02-26 |
2005-12-12 |
Sugen Inc |
Compuestos de aminoheteroarilo como inhibidores de proteina cinasa.
|
|
CA2530281C
(en)
*
|
2003-07-24 |
2013-02-12 |
Bayer Pharmaceuticals Corporation |
Substituted tetrahydrobenzothienopyrimidinamine compounds useful for treating hyper-proliferative disorders
|
|
EP1663211B1
(en)
*
|
2003-08-06 |
2010-01-20 |
Vertex Pharmaceuticals Incorporated |
Aminotriazole compounds useful as inhibitors of protein kinases
|
|
US7501427B2
(en)
|
2003-08-14 |
2009-03-10 |
Array Biopharma, Inc. |
Quinazoline analogs as receptor tyrosine kinase inhibitors
|
|
US7452895B2
(en)
|
2003-08-14 |
2008-11-18 |
Array Biopharma Inc. |
Quinazoline analogs as receptor tyrosine kinase inhibitors
|
|
MXPA06002296A
(es)
|
2003-08-29 |
2006-05-22 |
Pfizer |
Tienopiridina-fenilacetamidas y sus derivados utiles como nuevos agentes antiangiogenicos.
|
|
AR045563A1
(es)
|
2003-09-10 |
2005-11-02 |
Warner Lambert Co |
Anticuerpos dirigidos a m-csf
|
|
US7332521B2
(en)
*
|
2003-09-25 |
2008-02-19 |
Wyeth |
Substituted indoles
|
|
US7419978B2
(en)
|
2003-10-22 |
2008-09-02 |
Bristol-Myers Squibb Company |
Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors
|
|
MXPA06007242A
(es)
|
2003-12-23 |
2006-08-18 |
Pfizer |
Nuevos derivados de quinolina.
|
|
US7470712B2
(en)
*
|
2004-01-21 |
2008-12-30 |
Bristol-Myers Squibb Company |
Amino-benzazoles as P2Y1 receptor inhibitors
|
|
CA2553513A1
(en)
*
|
2004-01-22 |
2005-08-04 |
Altana Pharma Ag |
N-4-(6- (heteo) aryl-pyrimidin-4-ylaminophenyl) -bezenesulfonamides as kinase inhibitors
|
|
WO2005116035A1
(en)
*
|
2004-05-27 |
2005-12-08 |
Pfizer Products Inc. |
Pyrrolopyrimidine derivatives useful in cancer treatment
|
|
GB0412467D0
(en)
*
|
2004-06-04 |
2004-07-07 |
Astrazeneca Ab |
Chemical compounds
|
|
WO2006000589A1
(en)
|
2004-06-28 |
2006-01-05 |
Altana Pharma Ag |
4,6-disubstituted pyrimidines and their use as protein kinase inhibitors
|
|
US20050288290A1
(en)
*
|
2004-06-28 |
2005-12-29 |
Borzilleri Robert M |
Fused heterocyclic kinase inhibitors
|
|
ES2438017T3
(es)
*
|
2004-07-30 |
2014-01-15 |
Methylgene Inc. |
Inhibidores de la señalización del receptor del VEGF y del receptor del HGF
|
|
PL1786785T3
(pl)
|
2004-08-26 |
2010-08-31 |
Pfizer |
Enancjomerycznie czyste związki aminoheteroarylowe jako kinazy białkowe
|
|
GB0423653D0
(en)
*
|
2004-10-25 |
2004-11-24 |
Piramed Ltd |
Pharmaceutical compounds
|
|
CA2583812A1
(en)
*
|
2004-10-28 |
2006-05-11 |
Irm Llc |
Compounds and compositions as hedgehog pathway modulators
|
|
US7576080B2
(en)
*
|
2004-12-23 |
2009-08-18 |
Memory Pharmaceuticals Corporation |
Certain thienopyrimidine derivatives as phosphodiesterase 10 inhibitors
|
|
MX2007008676A
(es)
*
|
2005-01-19 |
2007-07-25 |
Hoffmann La Roche |
Derivados de 5-aminoindol.
|
|
DE602006016085D1
(de)
|
2005-03-16 |
2010-09-23 |
Genentech Inc |
Biologische marker prediktiv für das ansprechen von krebs auf inhibitoren der kinase des rezeptors für epidermalen wachstumsfaktor
|
|
EP1863848A4
(en)
|
2005-03-31 |
2009-09-23 |
Agensys Inc |
CORRESPONDING ANTIBODIES AND MOLECULES THAT ATTACH PROTEINS 161P2F10B
|
|
EP1877444A2
(en)
|
2005-04-26 |
2008-01-16 |
Pfizer, Inc. |
P-cadherin antibodies
|
|
BRPI0610322B8
(pt)
*
|
2005-05-20 |
2021-05-25 |
Methylgene Inc |
inibidores de sinalização de receptor de vegf e de receptor de hgf e composição farmacêutica
|
|
CA2608726C
(en)
|
2005-05-20 |
2013-07-09 |
Methylgene Inc. |
Inhibitors of vegf receptor and hgf receptor signaling
|
|
US20060281768A1
(en)
*
|
2005-06-10 |
2006-12-14 |
Gaul Michael D |
Thienopyrimidine and thienopyridine kinase modulators
|
|
JP5301986B2
(ja)
*
|
2005-06-22 |
2013-09-25 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
医薬組成物用のチエノピリミジン類
|
|
US7608592B2
(en)
|
2005-06-30 |
2009-10-27 |
Virobay, Inc. |
HCV inhibitors
|
|
WO2007026221A2
(en)
*
|
2005-09-02 |
2007-03-08 |
Pfizer Inc. |
Improved methods for preparing benzofused heteroaryl amide derivatives of thienopyridines
|
|
EA201300320A1
(ru)
|
2005-09-07 |
2014-02-28 |
Эмджен Фримонт Инк. |
Моноклональные антитела человека к киназе-1, подобной рецептору активина
|
|
WO2007035744A1
(en)
|
2005-09-20 |
2007-03-29 |
Osi Pharmaceuticals, Inc. |
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
|
|
AR056200A1
(es)
*
|
2005-09-27 |
2007-09-26 |
Wyeth Corp |
Tieno [2,3-b]piridin-5-carbonitrilos como inhibidores de proteina quinasa
|
|
US20070213305A1
(en)
*
|
2005-11-02 |
2007-09-13 |
Cytovia, Inc. |
N-alkyl-N-aryl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
|
|
WO2007056208A2
(en)
*
|
2005-11-02 |
2007-05-18 |
Cytovia, Inc. |
N-arylalkyl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
|
|
US20070099877A1
(en)
*
|
2005-11-02 |
2007-05-03 |
Cytovia, Inc. |
N-aryl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
|
|
ZA200804498B
(en)
|
2005-11-15 |
2009-07-29 |
Array Biopharma Inc |
N4-phenyl-quinazoline-4 -amine derivatives and related compounds as ERBB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
|
|
JP2009526761A
(ja)
*
|
2006-01-30 |
2009-07-23 |
アレイ バイオファーマ、インコーポレイテッド |
ヘテロ二環式チオフェン化合物および使用の方法
|
|
WO2007107005A1
(en)
*
|
2006-03-22 |
2007-09-27 |
Methylgene, Inc. |
Inhibitors of protein tyrosine kinase activity
|
|
EP2001480A4
(en)
*
|
2006-03-31 |
2011-06-15 |
Abbott Lab |
Indazole CONNECTIONS
|
|
EP2004656B1
(en)
*
|
2006-04-07 |
2013-07-10 |
Boehringer Ingelheim International GmbH |
Thienopyrimidines having mnk1 /mnk2 inhibiting activity for pharmaceutical compositions
|
|
CA2651629A1
(en)
|
2006-05-09 |
2007-11-22 |
Pfizer Products Inc. |
Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
|
|
EP1889847A1
(en)
|
2006-07-10 |
2008-02-20 |
DeveloGen Aktiengesellschaft |
Pyrrolopyrimidines for pharmaceutical compositions
|
|
SG176461A1
(en)
|
2006-11-06 |
2011-12-29 |
Supergen Inc |
Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors
|
|
MY180595A
(en)
|
2006-12-07 |
2020-12-03 |
Genentech Inc |
Phosphoinositide 3-kinase inhibitor compounds and methods of use
|
|
WO2008082839A2
(en)
*
|
2006-12-29 |
2008-07-10 |
Abbott Laboratories |
Pim kinase inhibitors as cancer chemotherapeutics
|
|
WO2008083356A1
(en)
*
|
2006-12-29 |
2008-07-10 |
Rigel Pharmaceuticals, Inc. |
Substituted triazoles useful as axl inhibitors
|
|
WO2008086053A1
(en)
*
|
2007-01-03 |
2008-07-17 |
Virobay, Inc. |
Hcv inhibitors
|
|
US7893060B2
(en)
*
|
2007-06-12 |
2011-02-22 |
F. Hoffmann-La Roche Ag |
Thiazolopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase
|
|
EP2014663A1
(de)
*
|
2007-07-12 |
2009-01-14 |
Bayer Schering Pharma AG |
Thienopyrimidylamine als Modulatoren des EP2-Rezeptors
|
|
EP2014662A1
(de)
*
|
2007-07-12 |
2009-01-14 |
Bayer Schering Pharma Aktiengesellschaft |
Indolylalkylthienopyrimidylamine als Modulatoren des EP2-Rezeptors
|
|
EP2207781B1
(en)
|
2007-09-24 |
2012-11-28 |
Genentech, Inc. |
Thiazolopyrimidine p13k inhibitor compounds and methods of use
|
|
NZ592534A
(en)
*
|
2007-10-18 |
2013-03-28 |
Boehringer Ingelheim Int |
Preparation of dihydrothieno [3,2-D] pyrimidines and intermediates used therein
|
|
WO2009055730A1
(en)
*
|
2007-10-25 |
2009-04-30 |
Genentech, Inc. |
Process for making thienopyrimidine compounds
|
|
BRPI0819328A8
(pt)
*
|
2007-11-15 |
2016-02-10 |
Boehringer Ingelheim Int |
Compostos inibidores de replicação de vírus da imunodeficiência humana, composição farmacêutica e uso dos ditos compostos
|
|
ES2734288T3
(es)
|
2007-11-28 |
2019-12-05 |
Dana Farber Cancer Inst Inc |
Inhibidores de miristato de moléculas pequeñas de Bcr-abl y métodos de uso
|
|
JP5419894B2
(ja)
*
|
2008-01-11 |
2014-02-19 |
グレンマーク ファーマシューティカルズ， エセ．アー． |
Ｔｒｐｖ３モジュレーターとしての縮合ピリミジン誘導体
|
|
MX2010008371A
(es)
|
2008-02-07 |
2010-10-04 |
Virobay Inc |
Inhibidores de catepsina b.
|
|
EP2262815A4
(en)
|
2008-03-05 |
2012-04-11 |
Methylgene Inc |
Inhibitors of protein intolerance activity
|
|
US8119647B2
(en)
*
|
2008-04-23 |
2012-02-21 |
Glenmark Pharmaceuticals S.A. |
Fused pyrimidineone compounds as TRPV3 modulators
|
|
NZ591113A
(en)
|
2008-08-26 |
2012-07-27 |
Boehringer Ingelheim Int |
Thienopyrimidine linked to phenyl or pyridine via an nh amine for pharmaceutical compositions
|
|
EP2334701A4
(en)
|
2008-10-16 |
2014-01-08 |
Univ Pittsburgh |
FULLY HUMAN ANTIBODIES AGAINST ANTIGENES ASSOCIATED WITH MELANOMA OF HIGH MOLECULAR WEIGHT AND USES THEREOF
|
|
KR101126736B1
(ko)
*
|
2008-11-27 |
2012-04-12 |
주식회사 레고켐 바이오사이언스 |
티로신 키나아제 저해 화합물, 이의 이성질체 또는 이의 약학적으로 허용가능한 염 및 이를 포함하는 약학적 조성물
|
|
US20100204221A1
(en)
|
2009-02-09 |
2010-08-12 |
Hariprasad Vankayalapati |
Pyrrolopyrimidinyl axl kinase inhibitors
|
|
US20120189641A1
(en)
|
2009-02-25 |
2012-07-26 |
OSI Pharmaceuticals, LLC |
Combination anti-cancer therapy
|
|
EP2400990A2
(en)
|
2009-02-26 |
2012-01-04 |
OSI Pharmaceuticals, LLC |
In situ methods for monitoring the emt status of tumor cells in vivo
|
|
TW201035088A
(en)
|
2009-02-27 |
2010-10-01 |
Supergen Inc |
Cyclopentathiophene/cyclohexathiophene DNA methyltransferase inhibitors
|
|
EP2401614A1
(en)
|
2009-02-27 |
2012-01-04 |
OSI Pharmaceuticals, LLC |
Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
|
|
US8465912B2
(en)
|
2009-02-27 |
2013-06-18 |
OSI Pharmaceuticals, LLC |
Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
|
|
WO2010099138A2
(en)
|
2009-02-27 |
2010-09-02 |
Osi Pharmaceuticals, Inc. |
Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
|
|
WO2010105008A2
(en)
|
2009-03-12 |
2010-09-16 |
Genentech, Inc. |
Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies
|
|
WO2010136491A1
(en)
*
|
2009-05-27 |
2010-12-02 |
F. Hoffmann-La Roche Ag |
Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
|
|
CN102459272B
(zh)
|
2009-05-27 |
2014-08-06 |
健泰科生物技术公司 |
对P110δ具有选择性的为PI3K抑制剂的二环嘧啶化合物和使用方法
|
|
SG10201510152RA
(en)
|
2009-07-13 |
2016-01-28 |
Genentech Inc |
Diagnostic methods and compositions for treatment of cancer
|
|
US20120128670A1
(en)
|
2009-07-31 |
2012-05-24 |
OSI Pharmaceuticals, LLC |
mTOR INHIBITOR AND ANGIOGENESIS INHIBITOR COMBINATION THERAPY
|
|
EP2473500A2
(en)
|
2009-09-01 |
2012-07-11 |
Pfizer Inc. |
Benzimidazole derivatives
|
|
CA2773662A1
(en)
|
2009-09-11 |
2011-03-17 |
Genentech, Inc. |
Method to identify a patient with an increased likelihood of responding to an anti-cancer agent
|
|
CA2772670A1
(en)
|
2009-09-17 |
2011-03-24 |
F. Hoffmann-La Roche Ag |
Methods and compositions for diagnostics use in cancer patients
|
|
WO2011073521A1
(en)
|
2009-12-15 |
2011-06-23 |
Petri Salven |
Methods for enriching adult-derived endothelial progenitor cells and uses thereof
|
|
CA3024216C
(en)
|
2010-02-12 |
2021-03-30 |
Pfizer Inc. |
Salts and polymorphs of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one
|
|
EP2539343B1
(en)
|
2010-02-26 |
2015-12-30 |
Evotec International GmbH |
Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions
|
|
KR20130008538A
(ko)
|
2010-02-26 |
2013-01-22 |
베링거 인겔하임 인터내셔날 게엠베하 |
약제학적 조성물을 위한 ｍｎｋ１／ｍｎｋ２ 억제 활성을 갖는 ４－［사이클로알킬옥시 （헤테로） 아릴아미노］ 티에노 ［２，３－ｄ］ 피리미딘
|
|
UY33241A
(es)
|
2010-02-26 |
2011-09-30 |
Boehringer Ingelheim Int |
?Tienopirimidinas que contienen heterocicloalquilo para composiciones farmacéuticas?.
|
|
WO2011109584A2
(en)
|
2010-03-03 |
2011-09-09 |
OSI Pharmaceuticals, LLC |
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
|
|
US20110275644A1
(en)
|
2010-03-03 |
2011-11-10 |
Buck Elizabeth A |
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
|
|
CA2793892A1
(en)
|
2010-04-16 |
2011-10-20 |
Elizabeth Punnoose |
Foxo3a as predictive biomarker for pi3k/akt kinase pathway inhibitor efficacy
|
|
CN102250112A
(zh)
*
|
2010-05-18 |
2011-11-23 |
上海再启生物技术有限公司 |
7-溴-4-氨基噻吩并嘧啶的制备方法
|
|
WO2011149126A1
(ko)
*
|
2010-05-26 |
2011-12-01 |
한국과학기술연구원 |
타이로신 카이네이즈 저해능을 가지는 항염증 화합물을 포함하는 약학적 조성물
|
|
HUE035589T2
(en)
|
2010-05-26 |
2018-05-28 |
Korea Inst Sci & Tech |
An anti-inflammatory compound having an anti-tyrosine kinase inhibitory activity and a pharmaceutical composition containing it
|
|
WO2011153224A2
(en)
|
2010-06-02 |
2011-12-08 |
Genentech, Inc. |
Diagnostic methods and compositions for treatment of cancer
|
|
CN104689314B
(zh)
|
2010-06-16 |
2018-02-02 |
高等教育联邦系统-匹兹堡大学 |
内质蛋白的抗体及其用途
|
|
EP2594566A4
(en)
|
2010-07-16 |
2014-10-01 |
Kyowa Hakko Kirin Co Ltd |
AROMATIC HETEROCYCLIC NITROGEN CYCLE DERIVATIVE
|
|
MX2013000667A
(es)
|
2010-07-19 |
2013-02-27 |
Hoffmann La Roche |
Metodo para identificar pacientes con probabilidad incrementada de responder a una terapia anticancer.
|
|
MX2013000672A
(es)
|
2010-07-19 |
2013-02-27 |
Hoffmann La Roche |
Metodo para identificar un paciente con probabilidad incrementada de responder a una terapia anti-cancer.
|
|
EP2596026B1
(en)
|
2010-07-23 |
2020-04-08 |
Trustees of Boston University |
Anti-despr inhibitors as therapeutics for inhibition of pathological angiogenesis and tumor cell invasiveness and for molecular imaging and targeted delivery
|
|
US9056832B2
(en)
|
2010-09-17 |
2015-06-16 |
Purdue Pharma L.P. |
Pyridine compounds and the users thereof
|
|
WO2012042421A1
(en)
|
2010-09-29 |
2012-04-05 |
Pfizer Inc. |
Method of treating abnormal cell growth
|
|
US9056865B2
(en)
|
2010-10-20 |
2015-06-16 |
Pfizer Inc. |
Pyridine-2-derivatives as smoothened receptor modulators
|
|
US20140004209A1
(en)
|
2010-12-22 |
2014-01-02 |
Genentech, Inc. |
Autophagy inducer and inhibitor combination therapy for the treatment of neoplasms
|
|
EP2670244B1
(en)
|
2011-02-04 |
2018-04-11 |
Duquesne University of The Holy Spirit |
Bicyclic and tricyclic pyrimidine tyrosine kinase inhibitors with antitubulin activity and methods of treating a patient
|
|
US20120214830A1
(en)
|
2011-02-22 |
2012-08-23 |
OSI Pharmaceuticals, LLC |
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors in hepatocellular carcinoma
|
|
WO2012142164A1
(en)
|
2011-04-12 |
2012-10-18 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Human monoclonal antibodies that bind insulin-like growth factor (igf) i and ii
|
|
EP3536708A1
(en)
|
2011-04-19 |
2019-09-11 |
Pfizer Inc |
Combinations of anti-4-1bb antibodies and adcc-inducing antibodies for the treatment of cancer
|
|
US9896730B2
(en)
|
2011-04-25 |
2018-02-20 |
OSI Pharmaceuticals, LLC |
Use of EMT gene signatures in cancer drug discovery, diagnostics, and treatment
|
|
AR088218A1
(es)
|
2011-07-19 |
2014-05-21 |
Infinity Pharmaceuticals Inc |
Compuestos heterociclicos utiles como inhibidores de pi3k
|
|
WO2013013188A1
(en)
|
2011-07-21 |
2013-01-24 |
Tolero Pharmaceuticals, Inc. |
Heterocyclic protein kinase inhibitors
|
|
EP2758402B9
(en)
|
2011-09-22 |
2016-09-14 |
Pfizer Inc |
Pyrrolopyrimidine and purine derivatives
|
|
EP3275902A1
(en)
|
2011-10-04 |
2018-01-31 |
IGEM Therapeutics Limited |
Ige anti-hmw-maa antibody
|
|
CN103087077B
(zh)
*
|
2011-11-03 |
2016-05-18 |
上海希迈医药科技有限公司 |
噻吩并嘧啶和呋喃并嘧啶类衍生物、其制备方法及其在医药上的应用
|
|
US20140286959A1
(en)
|
2011-11-08 |
2014-09-25 |
Pfizer Inc. |
Methods of Treating Inflammatory Disorders Using Anti-M-CSF Antibodies
|
|
KR20140110066A
(ko)
|
2012-01-10 |
2014-09-16 |
에프. 호프만-라 로슈 아게 |
티에노피리미딘 화합물
|
|
FR2988722B1
(fr)
|
2012-04-03 |
2014-05-09 |
Sanofi Sa |
Nouveaux derives de thienopyrimidines, leurs procedes de preparation et leurs utilisations therapeutiques
|
|
WO2013152252A1
(en)
|
2012-04-06 |
2013-10-10 |
OSI Pharmaceuticals, LLC |
Combination anti-cancer therapy
|
|
CN103360407B
(zh)
*
|
2012-04-10 |
2016-06-22 |
上海希迈医药科技有限公司 |
一种噻吩并嘧啶类衍生物、其制备方法及其在医药上的应用
|
|
CN103664991B
(zh)
*
|
2012-09-19 |
2016-12-28 |
中国科学院福建物质结构研究所 |
噻吩[2,3‑d]嘧啶衍生物、其制备方法及其用途
|
|
JP6243918B2
(ja)
|
2012-10-16 |
2017-12-06 |
トレロ ファーマシューティカルズ， インコーポレイテッド |
Ｐｋｍ２調節因子およびそれらの使用方法
|
|
US9260426B2
(en)
|
2012-12-14 |
2016-02-16 |
Arrien Pharmaceuticals Llc |
Substituted 1H-pyrrolo [2, 3-b] pyridine and 1H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors
|
|
EP2959014B1
(en)
|
2013-02-25 |
2019-11-13 |
Genentech, Inc. |
Methods and compositions for detecting and treating drug resistant akt mutant
|
|
TR201911151T4
(tr)
|
2013-03-14 |
2019-08-21 |
Tolero Pharmaceuticals Inc |
Jak2 ve alk2 inhibitörleri ve bunların kullanım yöntemleri.
|
|
US9206188B2
(en)
|
2013-04-18 |
2015-12-08 |
Arrien Pharmaceuticals Llc |
Substituted pyrrolo[2,3-b]pyridines as ITK and JAK inhibitors
|
|
AR096654A1
(es)
*
|
2013-06-20 |
2016-01-27 |
Ab Science |
Derivados de benzimidazol como inhibidores selectivos de proteína quinasa
|
|
US20150104392A1
(en)
|
2013-10-04 |
2015-04-16 |
Aptose Biosciences Inc. |
Compositions, biomarkers and their use in the treatment of cancer
|
|
UA115388C2
(uk)
|
2013-11-21 |
2017-10-25 |
Пфайзер Інк. |
2,6-заміщені пуринові похідні та їх застосування в лікуванні проліферативних захворювань
|
|
ES2896404T3
(es)
|
2014-04-04 |
2022-02-24 |
Crown Bioscience Inc Taicang |
Métodos para determinar la capacidad de respuesta a inhibidores de MEK/ERK
|
|
WO2015155624A1
(en)
|
2014-04-10 |
2015-10-15 |
Pfizer Inc. |
Dihydropyrrolopyrimidine derivatives
|
|
AP2016009530A0
(en)
|
2014-04-30 |
2016-10-31 |
Pfizer |
Cycloalkyl-linked diheterocycle derivatives
|
|
WO2016001789A1
(en)
|
2014-06-30 |
2016-01-07 |
Pfizer Inc. |
Pyrimidine derivatives as pi3k inhibitors for use in the treatment of cancer
|
|
KR20170031097A
(ko)
*
|
2014-07-16 |
2017-03-20 |
노보겐 리미티드 |
항암제로서 작용화되고 치환된 인돌
|
|
JP6811706B2
(ja)
|
2014-07-31 |
2021-01-13 |
ザ ホンコン ユニヴァーシティ オブ サイエンス アンド テクノロジー |
Ｅｐｈａ４に対するヒトモノクローナル抗体及びそれらの使用
|
|
EP3233829B1
(en)
|
2014-12-18 |
2019-08-14 |
Pfizer Inc |
Pyrimidine and triazine derivatives and their use as axl inhibitors
|
|
CA2982928A1
(en)
|
2015-04-20 |
2016-10-27 |
Tolero Pharmaceuticals, Inc. |
Predicting response to alvocidib by mitochondrial profiling
|
|
CN107709344B
(zh)
|
2015-05-01 |
2022-07-15 |
共晶制药股份有限公司 |
用于治疗黄病毒科病毒和癌症的核苷类似物
|
|
KR102608921B1
(ko)
|
2015-05-18 |
2023-12-01 |
스미토모 파마 온콜로지, 인크. |
생체 이용률이 증가된 알보시딥 프로드러그
|
|
WO2017009751A1
(en)
|
2015-07-15 |
2017-01-19 |
Pfizer Inc. |
Pyrimidine derivatives
|
|
CN108289861B
(zh)
|
2015-08-03 |
2021-11-02 |
大日本住友制药肿瘤公司 |
用于治疗癌症的组合疗法
|
|
US20180371551A1
(en)
|
2015-12-03 |
2018-12-27 |
Agios Pharmaceuticals, Inc. |
Mat2a inhibitors for treating mtap null cancer
|
|
BR112018012914B1
(pt)
|
2015-12-22 |
2023-04-18 |
SHY Therapeutics LLC |
Composto, uso de um composto e composição farmacêutica
|
|
CN109071528B
(zh)
*
|
2016-03-11 |
2023-02-17 |
Ac免疫有限公司 |
用于诊断和治疗的双环化合物
|
|
CN107652273B
(zh)
*
|
2016-07-26 |
2020-05-01 |
沈阳药科大学 |
嘧啶类衍生物及其制备方法和应用
|
|
WO2018094275A1
(en)
|
2016-11-18 |
2018-05-24 |
Tolero Pharmaceuticals, Inc. |
Alvocidib prodrugs and their use as protein kinase inhibitors
|
|
WO2018119000A1
(en)
|
2016-12-19 |
2018-06-28 |
Tolero Pharmaceuticals, Inc. |
Profiling peptides and methods for sensitivity profiling
|
|
SG11201911929XA
(en)
|
2017-06-21 |
2020-01-30 |
SHY Therapeutics LLC |
Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
|
|
US11497756B2
(en)
|
2017-09-12 |
2022-11-15 |
Sumitomo Pharma Oncology, Inc. |
Treatment regimen for cancers that are insensitive to BCL-2 inhibitors using the MCL-1 inhibitor alvocidib
|
|
WO2019075367A1
(en)
|
2017-10-13 |
2019-04-18 |
Tolero Pharmaceuticals, Inc. |
PKM2 ACTIVATORS IN COMBINATION WITH OXYGEN REACTIVE SPECIES FOR THE TREATMENT OF CANCER
|
|
CA3103995A1
(en)
|
2018-07-26 |
2020-01-30 |
Sumitomo Dainippon Pharma Oncology, Inc. |
Methods for treating diseases associated with abnormal acvr1 expression and acvr1 inhibitors for use in the same
|
|
US11034710B2
(en)
|
2018-12-04 |
2021-06-15 |
Sumitomo Dainippon Pharma Oncology, Inc. |
CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer
|
|
AR117472A1
(es)
|
2018-12-21 |
2021-08-11 |
Celgene Corp |
Inhibidores de tienopiridina de ripk2
|
|
MX2021009371A
(es)
|
2019-02-12 |
2021-09-10 |
Sumitomo Pharma Oncology Inc |
Formulaciones que comprenden inhibidores de proteina cinasa heterociclicos.
|
|
US20220056043A1
(en)
*
|
2019-02-19 |
2022-02-24 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
Nitrogen-containing fused cyclic compound, preparation method therefor and use thereof
|
|
US20230148450A9
(en)
*
|
2019-03-01 |
2023-05-11 |
Revolution Medicines, Inc. |
Bicyclic heteroaryl compounds and uses thereof
|
|
US11793802B2
(en)
|
2019-03-20 |
2023-10-24 |
Sumitomo Pharma Oncology, Inc. |
Treatment of acute myeloid leukemia (AML) with venetoclax failure
|
|
MX2021011289A
(es)
|
2019-03-22 |
2021-11-03 |
Sumitomo Pharma Oncology Inc |
Composiciones que comprenden moduladores de isoenzima m2 muscular de piruvato cinasa pkm2 y metodos de tratamiento que usan las mismas.
|
|
CN114269753B
(zh)
*
|
2019-09-29 |
2024-03-05 |
四川科伦博泰生物医药股份有限公司 |
一种含氮并环类化合物，包含其的药物组合物，其制备方法及其用途
|
|
PE20221581A1
(es)
*
|
2019-12-12 |
2022-10-06 |
Ptc Therapeutics Inc |
Compuestos para tratar la disautonomia familiar
|
|
WO2021155006A1
(en)
|
2020-01-31 |
2021-08-05 |
Les Laboratoires Servier Sas |
Inhibitors of cyclin-dependent kinases and uses thereof
|
|
CN115746017B
(zh)
*
|
2022-11-30 |
2024-06-07 |
英维沃化工科技(广州)有限公司 |
一种噻吩并嘧啶类化合物及其制备方法和应用
|